126 related articles for article (PubMed ID: 15114817)
1. Managing prostate cancer.
Gillmore R
Practitioner; 2004 Apr; 248(1657):274-80. PubMed ID: 15114817
[No Abstract] [Full Text] [Related]
2. Prostate cancer after exogenous testosterone replacement therapy in a patient with pituitary insufficiency.
Halland A; Jønler M; Pedersen KV
Scand J Urol Nephrol; 2005; 39(1):87-8. PubMed ID: 15764279
[TBL] [Abstract][Full Text] [Related]
3. FPIN's clinical inquiries. Testosterone therapy and risk recurrence after treatment of prostate cancer.
Meza J; Weaver K; Martin S
Am Fam Physician; 2013 Oct; 88(8):Online. PubMed ID: 24364582
[No Abstract] [Full Text] [Related]
4. Testosterone administration to men with testosterone deficiency syndrome after external beam radiotherapy for localized prostate cancer: preliminary observations.
Morales A; Black AM; Emerson LE
BJU Int; 2009 Jan; 103(1):62-4. PubMed ID: 18671790
[TBL] [Abstract][Full Text] [Related]
5. [Androgen deficiency in males and its correction in respect to pathogenesis of prostatic cancer].
Mazo EB; Grigor'ev ME; Konorev VA; Ermisheva OM
Urologiia; 2008; (3):57-8, 60-2. PubMed ID: 18669351
[No Abstract] [Full Text] [Related]
6. Low testosterone and risk of biochemical recurrence and poorly differentiated prostate cancer at radical prostatectomy.
Lane BR; Stephenson AJ; Magi-Galluzzi C; Lakin MM; Klein EA
Urology; 2008 Dec; 72(6):1240-5. PubMed ID: 18692874
[TBL] [Abstract][Full Text] [Related]
7. Editorial comment on: A randomized phase 1 study of testosterone replacement for patients with low-risk castration-resistant prostate cancer.
van der Poel HG
Eur Urol; 2009 Jul; 56(1):103-4. PubMed ID: 19282103
[No Abstract] [Full Text] [Related]
8. [Prostate carcinoma: many developments in diagnosis and treatment].
Graefen M; Huland H
Urologe A; 2003 Sep; 42(9):1170-1. PubMed ID: 14619839
[No Abstract] [Full Text] [Related]
9. Prevention of prostate cancer by androgens: experimental paradox or clinical reality.
Algarté-Génin M; Cussenot O; Costa P
Eur Urol; 2004 Sep; 46(3):285-94; discussion 294-5. PubMed ID: 15306098
[TBL] [Abstract][Full Text] [Related]
10. Testosterone therapy in men with prostate cancer: scientific and ethical considerations.
Morgentaler A
J Urol; 2009 Mar; 181(3):972-9. PubMed ID: 19150547
[TBL] [Abstract][Full Text] [Related]
11. Notice of duplicate publication: "Potentially harmful effect of a testosterone dietary supplement on prostate cancer growth and metastasis" (arch intern med. 2008;168[2]:235-236).
Shariat SF; Roehrborn CG; Lamb DJ; Slawin KM
Arch Intern Med; 2008 Oct; 168(18):2046-7. PubMed ID: 18852410
[No Abstract] [Full Text] [Related]
12. Testosterone replacement therapy after primary treatment for prostate cancer.
Agarwal PK; Oefelein MG
J Urol; 2005 Feb; 173(2):533-6. PubMed ID: 15643240
[TBL] [Abstract][Full Text] [Related]
13. [Prostate cancer: news in 2008].
Salomon L; Descazeaud A
Prog Urol; 2008 Sep; 18 Suppl 6():S116-24. PubMed ID: 18822261
[TBL] [Abstract][Full Text] [Related]
14. Use of testosterone in men with prostate cancer and suggestions for an international registry.
Morales A
BJU Int; 2011 May; 107(9):1343-4. PubMed ID: 21518226
[No Abstract] [Full Text] [Related]
15. Testosterone therapy in the ageing male: what about the prostate?
Schultheiss D; Machtens S; Jonas U
Andrologia; 2004 Dec; 36(6):355-65. PubMed ID: 15541051
[TBL] [Abstract][Full Text] [Related]
16. Postprostatectomy target-normal structure overlap volume differences using computed tomography and radioimmunoscintigraphy images for radiotherapy treatment planning.
Su A; Blend MJ; Spelbring D; Hamilton RJ; Jani AB
Clin Nucl Med; 2006 Mar; 31(3):139-44. PubMed ID: 16495731
[TBL] [Abstract][Full Text] [Related]
17. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer in men using testosterone supplementation.
Gaylis FD; Lin DW; Ignatoff JM; Amling CL; Tutrone RF; Cosgrove DJ
J Urol; 2005 Aug; 174(2):534-8; discussion 538. PubMed ID: 16006887
[TBL] [Abstract][Full Text] [Related]
19. [Problems of treatment of prostatic cancer].
Rutkowski A
Wiad Lek; 1980 Sep; 33(18):1461-6. PubMed ID: 6781145
[No Abstract] [Full Text] [Related]
20. Endorectal MRI assessment of local relapse after surgery for prostate cancer: A model to define treatment field guidelines for adjuvant radiotherapy in patients at high risk for local failure.
Miralbell R; Vees H; Lozano J; Khan H; Mollà M; Hidalgo A; Linero D; Rouzaud M
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):356-61. PubMed ID: 17236961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
